Mohama Fairus et al. demonstrated that DHODH inhibitors, including brequinar sodium (BQR), leflunomide, and 4SC-101 provoked ROS generation and ATP depletion by a p53-mediated route, thereby suppressing BC cell proliferation [62]. This evidence concerns the gene DHODH and breast cancer.